NY A10475 | 2021-2022 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Engrossed on June 3 2022 - 50% progression, died in committee
Action: 2022-06-03 - REFERRED TO RULES
Pending: Senate Rules Committee
Text: Latest bill text (Introduced) [HTML]
Status: Engrossed on June 3 2022 - 50% progression, died in committee
Action: 2022-06-03 - REFERRED TO RULES
Pending: Senate Rules Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires the Superintendent of Financial Services to refer the drug insulin to the Drug Accountability Board for examination related to price increases and consumer impact.
Title
Requires the Superintendent of Financial Services to refer the drug insulin to the Drug Accountability Board for examination related to price increases and consumer impact.
Sponsors
Roll Calls
2022-06-03 - Assembly - Assembly Floor Vote - Final Passage (Y: 149 N: 0 NV: 0 Abs: 1) [PASS]
2022-06-02 - Assembly - Assembly Rules Committee: Favorable (Y: 27 N: 0 NV: 0 Abs: 4) [PASS]
2022-06-01 - Assembly - Assembly Ways And Means Committee: Favorable refer to committee Rules (Y: 33 N: 0 NV: 0 Abs: 2) [PASS]
2022-06-02 - Assembly - Assembly Rules Committee: Favorable (Y: 27 N: 0 NV: 0 Abs: 4) [PASS]
2022-06-01 - Assembly - Assembly Ways And Means Committee: Favorable refer to committee Rules (Y: 33 N: 0 NV: 0 Abs: 2) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2022-06-03 | Senate | REFERRED TO RULES |
| 2022-06-03 | Assembly | delivered to senate |
| 2022-06-03 | Assembly | passed assembly |
| 2022-06-02 | Assembly | ordered to third reading rules cal.652 |
| 2022-06-02 | Assembly | rules report cal.652 |
| 2022-06-02 | Assembly | reported |
| 2022-06-01 | Assembly | reported referred to rules |
| 2022-05-31 | Assembly | reference changed to ways and means |
| 2022-05-27 | Assembly | referred to insurance |
